We examined the ability of lymphoblastoid-myeloid cell lines to bind, ingest, and permit multiplication of Chiamydia trachomatis (L2 serovar). Four types of chlamydia-cell line interactions were observed: (i) minimal bacterial binding; (ii) bacterial binding, followed by ingestion and high-level multiplication; (iii) bacterial binding, followed by ingestion but minimal multiplication; and (iv) bacterial binding, but minimal ingestion or replication. Our data demonstrate that at 37°C in vitro the L2 serovar can both bind avidly to a cell without entering it and enter nonphagocytic cells but not grow.
Chlamydia are obligate intracellular bacteria that can infect fibroblast and epithelial cell lines in vitro (8) and also enter granulocytes and macrophages (17; K. Register, P. Wyrick, W. Shafer, and J. K. Spitznagel, Abstr. Annu. Meet. Am. Soc. Microbiol., D6, p. 52). Binding of chlamydia at 37°C by these cells leads directly to bacterial uptake, with ensuing growth, latency, or destruction (10) .
We recently demonstrated that the L2 strain (lymphogranuloma venereum [ LGV] biovar) of Chlamydia trachomatis will bind to but not enter a subpopulation (Ca. 50%) of human peripheral blood B lymphocytes (J. Bard and D. Levitt, Clin. Immunol. Immunopathol., in press). To develop a system for evaluating different types of chlamydiamammalian cell interactions, we analyzed binding to, entrance of, and growth of L2 serovar in several human leukocyte cell lines and compared these interactions with those of a prototype fibroblast cell line (McCoy). Our results demonstrate four distinct types of chlamydia-host cell interactions at 37°C: (i) minimal to no bacterial binding, (ii) bacterial binding, followed by ingestion and high-level multiplication, (iii) bacterial binding, followed by ingestion but minimal multiplication, and (iv) bacterial binding, but minimal entrance or replication.
Chlamydia trachomatis (L2 serovar; L2/434/Bu) was isolated in McCoy cells and purified on Renograffin gradients (2) . Cell lines were grown in RPMI 1640 containing 10% fetal bovine serum, 2 mM L-glutamine, and gentamicin (10 ,ug/ml) (complete media) and were screened monthly for mycoplasma contamination (7) . All cell lines were cloned in soft agar within 3 months of initiation.
Binding and ingestion of L2 were assessed by an immunofluorescence assay (Bard and Levitt, in press) using fluorescein-conjugated mouse monoclonal antibody specific for the L2 serovar (kindly provided by M. Tam, Genetic Systems, Seattle, Wash. [15] ) and an irrelevant fluorescein-conjugated mouse immunoglobulin G, MOPC21, as control. Positive cells were evaluated using a Nikon Optiphot fluorescence microscope equipped with epi-illumination; 1,000 to 1,500 cells were counted on each slide.
To monitor the ingestion of chlamydiae, cells were incubated with L2 for 3 to 4 h in complete medium to permit the uptake of surface-bound bacteria. Cells were then treated with pronase (4 mg/ml in Hanks balanced salt solution) for 45 * Corresponding author. min at 37°C to remove surface-bound chlamydiae from cells (4-6) or a protease-sensitive molecule recognized by the monoclonal antibody from the bacteria (15; unpublished observations). Only extracellular bacteria were affected by this treatment. Cells were then stained with the fluoresceinconjugated mouse anti-L2 antibody.
To investigate the growth of bacteria within each cell line, chlamydiae were centrifuged onto 2 x 106 cells (multiplicity of infection [10:1] previously determined to be optimum for four of the cell lines tested), washed, and then resuspended in complete medium containing cycloheximide (1 pLg/ml). Samples were incubated for either 32 or 48 to 72 h and examined for inclusion bodies (indicative of bacterial growth) or infectious progeny, respectively. The percentage of cells with inclusion bodies was determined by immunofluorescence using fluorescein-conjugated mouse anti-L2 antibody. The yield of infectious C. trachomatis was assessed by titration in McCoy cells (2, 13) and represented as inclusion-forming units per milliliter of culture supernatant according to the method of Rothermel et al. (13) .
Four patterns of interaction between the leukocyte cell lines and L2 were apparent (Table 1) . Two cell lines possessed fewer than 5% of cells binding chlamydiae (group I, Table 1 ). Six cell lines exhibited significant chlamydial binding (20 to 90% of the cells bound L2), although minimal entrance or growth of bacteria within cells occurred (group II, Table 1 ). Two cell lines demonstrated sizeable populations of cells which chlamydia bound to and entered, yet bacterial proliferation was hindered (as evidenced by reduced percentages of inclusion-containing cells compared with significant numbers [>20%] of ingesting cells (group III, Table 1 ). One cell line (Rienta) possessed a large population of cells (50%) which bound ( Fig. 1) , ingested, and permitted productive multiplication of L2 (group IV, Table 1 ; Fig. 1 ). The prototype cell line (McCoy) exhibited the greatest degree of binding, ingestion, and multiplication of bacteria (group IV, Table 1 ).
Chlamydial attachment appeared to be specific for each cell line for three reasons: (i) different percentages (0. Despite their clonal derivation, only a fraction of cells from each leukocyte line could bind L2. Binding may correlate with cell cycle status, expression of specific chlamydiabinding molecules, or receptor metabolism. We are currently analyzing these questions using fluorescence-activated cell sorting of chlamydia-binding, synchronized cell populations.
Previous studies have assessed interactions between chlamydiae and cell lines which are believed to be representative of normal hosts (epithelial cells, fibroblasts) or "professional" phagocytes (macrophages, granulocytes) Register et al., Abstr. Annu. Meet (3, 11, 13) .
Finally, analysis of chlamydial interactions with leukocyte cell lines has provided two new pieces of information. (i)
Even under normal in vitro growth conditions, LOV can bind avidly to a cell without entering it. (ii) LGV can enter nonphagocytic cell types but not grow. Although we do not know how these cells prevent the erltrance of chlamydiae or modify their growth, they provide excellent model systems with which to examine these issues. We are currently studying interactions between B-strain chlamydiae and leukocyte cell lines and separating chlamydia-binding subpopulations with a fluorescence-activated cell sorter.
